ADENOCARCINOMAL TUMOR OF THE COLON ARISING IN PREEXISTING ULCERATIVE COLITISLYSS AP; THOMPSON JJ; GLICK JH et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 3; PP. 833-839; BIBL. 13 REF.Article

THE ROLE OF COMBINED MODALITY THERAPY IN THE TREATMENT OF STAGE IIIA HODGKIN'S DISEASEDEVITA VT JR; PROSNITZ LR; GLICK JH et al.1979; INTERNATION. J. RAD. ONCOL. BIOL. PHYS.; USA; DA. 1979; VOL. 5; NO 6; PP. 913-914; BIBL. 6 REF.Article

A SYSTEM FOR MONITORING CRYING AND NONCRYING, LARGE, MEDIUM, AND SMALL NEONATAL MOVEMENTS = UN SYSTEME POUR ENREGISTRER LA PERIODE DES CRIS D'ACTIVITE TRANQUILLE ET DES MOUVEMENTS CORPORELS DE FAIBLE, MOYENNE ET GRANDE AMPLITUDE CHEZ LE NOUVEAU-NEKORNER AF; THOMAN EB; GLICK JH et al.1974; CHILD DEVELOP.; U.S.A.; DA. 1974; VOL. 45; NO 4; PP. 946-952; BIBL. 21REF.Article

RANDOMIZED CLINICAL TRIAL COMPARING TWO DOSE REGIMENS OF ICRF-159 IN REFRACTORY MALIGNANT LYMPHOMASO'CONNELL MJ; BEGG CB; SILVERSTEIN MN et al.1980; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1980; VOL. 64; NO 12; PP. 1355-1358; BIBL. 4 REF.Article

PHASE II STUDY OF MAYTANSINE IN PATIENTS WITH ADVANCED LYMPHOMAS: AN EASTERN COOPERATIVE ONCOLOGY GROUP PILOT STUDYROSENTHAL S; HARRIS DT; HORTON J et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 10-11; PP. 1115-1117; BIBL. 9 REF.Article

THE ADJUVANT TREATMENT OF INOPERABLE STAGE III AND IV EPIDERMOID CARCINOMA OF THE HEAD AND NECK WITH PLATINUM AND BLEOMYCIN INFUSIONS PRIOR TO DEFINITIVE RADIOTHERAPY: AN RTOB PILOT STUDYGLICK JH; MARCIAL V; RICHTER M et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 9; PP. 1919-1924; BIBL. 13 REF.Article

NON-HODGKIN'S LYMPHOMA IN SYSTEMIC LUPUS ERYTHEMATOSUS. REPORT OF 4 CASES WITH ULTRASTRUCTURAL STUDIES IN 2AGUDELO CA; SCHUMACHER HR; GLICK JH et al.1981; J. RHEUMATOL.; ISSN 0315-162X; CAN; DA. 1981; VOL. 8; NO 1; PP. 69-78; BIBL. 37 REF.Article

PHASE II TRIAL OF TAMOXIFEN IN METASTATIC CARCINOMA OF THE PROSTATEGLICK JH; WEIN A; PADAVIC K et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 7; PP. 1367-1372; BIBL. 22 REF.Article

COMPARATIVE TRIAL OF TWO TENIPOSIDE-BASED COMBINATION CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF ADVANCED MALIGNANT LYMPHOMAS = ESSAI COMPARANT DEUX PROTOCOLES DE CHIMIOTHERAPIE COMBINEE COMPRENANT DU V.M 26 DANS LE TRAITEMENT DES LYMPHOMES MALINS AVANCESO'CONNELL MJ; ANDERSON J; MERRILL JM et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 12; PP. 2021-2025; ABS. ENG; BIBL. 12 REF.; GRAPHArticle

NODULAR HISTIOCYTIC LYMPHOMA: FACTORS INFLUENCING PROGNOSIS AND IMPLICATIONS FOR AGGRESSIVE CHEMOTHERAPYGLICK JH; MCFADDEN E; COSTELLO W et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 5; PP. 840-845; BIBL. 20 REF.Article

PHASE II STUDY OF TAMOXIFEN IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMAGLICK JH; WEIN A; TORRI S et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 2-3; PP. 343-344; BIBL. 10 REF.Article

LYMPHOBLASTIC LYMPHOMA: A CLINICOPATHOLOGIC STUDY OF 95 PATIENTSNATHWANI BN; DIAMOND LW; WINBERG CD et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 11; PP. 2347-2357; BIBL. 29 REF.Article

THE INFLUENCE OF HISTOLOGIC SUBTYPE ON TOXICITY AND RESPONSE TO CHEMOTHERAPY IN NON-HODGKIN'S LYMPHOMA. AN EASTERN COOPERATIVE ONCOLOGY GROUP STUDY UTILIZING THE BCVP REGIMEN = L'INFLUENCE DU SOUS-TYPE HISTOLOGIQUE SUR LA TOXICITE ET LA REPONSE A LA CHIMIOTHERAPIE DANS LE LYMPHOME NON HODGKINIEN. UNE ETUDE DE L'EASTERN COOPERATIVE ONCOLOGY GROUP UTILISANT LE REGIME BCVPOKEN MM; COSTELLO WG; JOHNSON GJ et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 9; PP. 1581-1586; ABS. ENG; BIBL. 22 REF.; GRAPHArticle